Crossmark

TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy

Crossref DOI link: https://doi.org/10.1186/s40425-019-0738-2

Published Online: 2019-10-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kang, Tae Heung

Mao, Chih-Ping

Kim, Young Seob

Kim, Tae Woo

Yang, Andrew

Lam, Brandon

Tseng, Ssu-Hsueh

Farmer, Emily

Park, Yeong-Min

Hung, Chien-Fu https://orcid.org/0000-0001-9170-7797
Funding

Funding for this research was provided by:

National Cancer Institute (P50 CA098252, R01 CA233486, F31 CA236051)

National Research Foundation of Korea (NRF-2016R1A5A2012284, NRF-2017R1A2A1A17069818, NRF-2018R1A2B6008455)

Korea Health Industry Development Institute (HI15C2524)

American Cancer Society (RSG-07-199-01-LIB)
License Information

Text and Data Mining valid from 2019-10-16
More Information

Article History

Received: 12 July 2019

Accepted: 11 September 2019

First Online: 16 October 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.